Express Pharma

JUNE 12, 2025

It places way more emphasis on hands- on training for pharmaceutics, medicinal chemistry, and pharmaceutical analysis while sidelining practicals in foundational sciences like human anatomy, physiology, patho- physiology, and clinical pharmacology.

Drug Development 59

Drug Development Clinical Pharmacology Dosage Compounding 59

PharmaFactz

APRIL 20, 2025

Methotrexate Pharmacology Here, we review the must-know facts about methotrexate pharmacology; an important drug that carries with it significant risks that healthcare professionals must be cognisant of. In this review, we learn more about the drug’s indications, mechanism of action, side effects, and clinical pharmacology.

Clinical Pharmacology 52

Clinical Pharmacology Chemotherapy Immunization Immunity 52

FDA Law Blog: Biosimilars

DECEMBER 6, 2024

The draft guidance includes FAQs covering topics from across disciplines: regulatory review; chemistry, manufacturing, and controls (CMC); nonclinical and pharmacology/toxicology (PT); clinical; and clinical pharmacology. Stay tuned for the next iteration of the Cliffs Notes to the Cliffs Notes.

Documentation 59

Documentation Packaging Clinical Pharmacology Drug Development 59

FDA Law Blog: Biosimilars

JULY 17, 2024

In December 2023, FDA established the Genetic Metabolic Diseases Advisory Committee (also called “GeMDAC,” which we blogged about here ) to advise FDA regarding treatments for genetic metabolic diseases (i.e., clinical pharmacology/biomarkers, animal models, real-world evidence and other externally controlled comparisons [e.g.,

Clinical Pharmacology 105

Clinical Pharmacology Drug Development 105

PharmaFactz

NOVEMBER 13, 2023

Clinical Pharmacology When we talk about the clinical pharmacology of H 2 antagonists, we need to think about the following factors: Cimetidine is associated with a greater number of side effects and drug interactions compared to later H 2 antagonists, such as famotidine. The post H2 Antagonists Pharmacology!

Clinical Pharmacology 52

Clinical Pharmacology 52

PharmaFactz

JANUARY 3, 2024

Clinical Pharmacology When we talk about the clinical pharmacology of nitrofurantoin, we need to think about the following factors: Nitrofurantoin should be avoided in renal impairment. That concludes our rapid revision of nitrofurantoin pharmacology! The post Nitrofurantoin Pharmacology!

Clinical Pharmacology 52

Clinical Pharmacology 52

PharmaFactz

NOVEMBER 29, 2023

Clinical Pharmacology When we talk about the clinical pharmacology of cyclosporine , we need to think about the following factors: Reduced doses are warranted in patients with cardiovascular disease , not least because cyclosporine is linked to hypertension. That concludes our rapid review of cyclosporine pharmacology!

Clinical Pharmacology 52

Clinical Pharmacology Immunization Immunity 52

PharmaFactz

DECEMBER 4, 2023

Clinical Pharmacology When we talk about the clinical pharmacology of aminoglycosides, we need to think about the following factors: Nephrotoxicity is accompanied by reduced urine production, elevated serum creatinine levels and rising urea levels. That concludes our rapid review of aminoglycosides pharmacology!

Clinical Pharmacology 52

Clinical Pharmacology Chemotherapy Hospitals 52

Pharmacy Joe

JANUARY 11, 2023

However, a study published in 2012 in BMC Clinical Pharmacology challenges that concept and seems to show that at very high doses there must be some form of passive, non-saturable absorption of thiamine. Healthy subjects were given oral thiamine at doses of 100 mg, 500 mg, and 1500 mg.

Clinical Pharmacology 52

Clinical Pharmacology Inpatient Hospitals 52

Pharmacy Joe

JANUARY 10, 2021

In 1989, a study in the Journal of Clinical Pharmacology compared 10, 30, and 90 mg of IM ketorolac with placebo in 126 patients with cancer pain. While all doses were more effective than placebo, there was no difference in effectiveness between 10, 30, or 90 mg of IM ketorolac.

Clinical Pharmacology 40

Clinical Pharmacology Inpatient Dosage Documentation 40

Pharmacy Joe

JANUARY 11, 2023

However, a study published in 2012 in BMC Clinical Pharmacology challenges that concept and seems to show that at very high doses there must be some form of passive, non-saturable absorption of thiamine. Healthy subjects were given oral thiamine at doses of 100 mg, 500 mg, and 1500 mg.

Clinical Pharmacology 40

Clinical Pharmacology Inpatient Hospitals 40

PharmaFactz

DECEMBER 17, 2023

Methotrexate Pharmacology Here, we review the must-know facts about methotrexate pharmacology; an important drug that carries with it significant risks that healthcare professionals must be cognisant of. In this review, we learn more about the drug’s indications, mechanism of action, side effects, and clinical pharmacology.

Clinical Pharmacology 52

Clinical Pharmacology Chemotherapy Immunity Immunization 52

PharmaFactz

JANUARY 10, 2024

Clinical Pharmacology When we discuss the clinical pharmacology of tetracyclines, we must consider the following factors. That completes our rapid revision review of tetracyclines pharmacology! Check back to our pharmacy blog soon for more exclusive content to help you master the science of drugs and medicines.

Clinical Pharmacology 52

Clinical Pharmacology Labelling 52

PharmaFactz

OCTOBER 15, 2023

Clinical Pharmacology When we think about the clinical pharmacology of triptans, we need to talk about the following factors: That triptans are classified as pregnancy category C in the United States, meaning risk is not ruled out . That concludes our rapid revision of triptans pharmacology.

Clinical Pharmacology 52

Clinical Pharmacology 52

PharmaFactz

DECEMBER 27, 2023

Clinical Pharmacology When we talk about the clinical pharmacology of dopamine agonists, we need to think about the following factors: Caution is warranted in elderly patients or in those with established psychiatric disease due to the twin risks of confusion and hallucinations. The post Dopamine Agonists Pharmacology!

Clinical Pharmacology 52

Clinical Pharmacology 52

Putting Patients First Blog

SEPTEMBER 26, 2024

Clinical Pharmacology & Therapeutics , 97(3) , 263–273. Participation of women in clinical trials supporting FDA approval of cardiovascular drugs. Pacanowski, M., and Zhang, L. Racial/ethnic differences in drug disposition and response: Review of recently approved drugs. 8 Scott, P., Jenkins, M., Southworth, M.,

Communication 52

Communication Clinical Pharmacology Documentation Drug Development 52

The Physician Pharmacist

OCTOBER 27, 2023

⚡️ For more resources to get started, check out some of our other blog post content! And so yeah, I'm the founding lecturer and basic clinical pharmacology to this PA program. I developed and implemented a whole course in clinical pharmacology 24 lectures, each lectures two and a half hours and exams and it was a lot of fun.

Medical Schools 52

Medical Schools Medical Records Hospitals Clinical Pharmacology 52

FDA Law Blog: Biosimilars

OCTOBER 28, 2024

The Guidance notes that extrapolation of data across species is challenging; however, in accord with Agency pronouncements elsewhere on this topic, the Guidance describes FDA’s limited experience with alternative assays to characterize neurodevelopmental toxicity while expressing a theoretical openness to such methods when feasible.

Clinical Pharmacology 64

Clinical Pharmacology Communication Drug Development 64